> Research summary — not medical advice. This page synthesizes published research on a mechanism-level intervention. It is not a clinical recommendation. Consult a qualified healthcare provider before making any changes to diet, supplementation, or treatment.
Intervention Summary
N-acetylcysteine as a glutathione precursor and glutamatergic modulator. Addresses the oxidative stress and glutathione depletion that are shared signature features across ASD, schizophrenia, Long COVID, Parkinson's disease, and conditions with heavy metal burden. NAC also supports phase II detoxification of toxic metals (Cd, Pb, Hg, As) via glutathione conjugation.
Evidence
- ASD: Multiple pilot RCTs show NAC (900-2700mg/day) reduces irritability scores on the ABC scale; effects on social communication less consistent
- Schizophrenia: Adjunctive NAC (2g/day) improves negative symptoms and working memory in multiple small RCTs; meta-analytic trend toward benefit
- Long COVID: Early trials show NAC reduces fatigue and improves cognitive function in post-acute sequelae
- Mis-metallation support: NAC-derived glutathione conjugates toxic metals for biliary and renal excretion
Mechanism
- Glutathione synthesis: NAC provides cysteine — the rate-limiting amino acid for glutathione (GSH) production. GSH is the master intracellular antioxidant depleted across multiple disease signatures
- Glutamatergic modulation: NAC activates the cystine-glutamate antiporter (system Xc-), increasing extracellular glutamate at extrasynaptic sites, which activates inhibitory mGluR2/3 receptors and reduces excitotoxicity
- Metal detoxification support: Glutathione conjugation is a primary phase II pathway for cadmium, lead, mercury, and arsenic elimination
- Anti-inflammatory: Reduces NF-kB activation and pro-inflammatory cytokine production
Clinical Context
NAC is well-tolerated (most common side effect: GI discomfort at higher doses) and inexpensive. Typical doses: 600-1800mg/day for general antioxidant support; 2000-2700mg/day in psychiatric applications. Best taken away from meals. Practitioners should note that NAC's glutamatergic effects make it a neuroactive compound — not merely a "supplement."
—-
> Educational content, not medical advice. This page describes mechanisms by which the intervention interacts with the microbiome and metal ecology. It is not a treatment recommendation. Clinical decisions about any intervention should be made with a qualified healthcare practitioner who knows your individual history.